Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo
Microvesicles shed from cells carry constituents of the cell cytoplasm, including, of importance in multidrug resistance to cancer chemotherapy, drugs that the tumor cell attempts to efflux. To see whether such drugs could be used at lower concentrations with the same efficacy, it was first shown th...
Main Authors: | Jorfi, Samireh, Ansa-Addo, Ephraim A., Kholia, Sharadkumar Rajnikant, Stratton, Dan, Valley, Shaunelle, Lange, Sigrun, Inal, Jameel |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Group Publishing
2015
|
Subjects: | |
Online Access: | https://repository.londonmet.ac.uk/1000/1/Sci%20Rep%202015.pdf |
Similar Items
-
A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy
by: Kholia, Sharadkumar Rajnikant, et al.
Published: (2015) -
The role of PADs in the biogenesis of prostate cancer microvesicles which play a dysfunctional role on DC biology and the therapeutic potential of skeletal muscle microvesicles on prostate cancer cells
by: Kholia, Sharadkumar Rajnikant
Published: (2014) -
Plasma mEV levels in Ghanain malaria patients with low parasitaemia are higher than those of healthy controls, raising the potential for parasite markers in mEVs as diagnostic targets
by: Antwi-Baffour, Samuel, et al.
Published: (2019) -
Animal models of human disease
by: Lange, Sigrun, et al.
Published: (2023) -
Plasma membrane-derived vesicles: composition and function
by: Ansa-Addo, Ephraim A.
Published: (2010)